Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kawaguchi Natto is a specialized Japanese producer of fermented soybean products, recognized for its commitment to traditional fermentation techniques and functional nutrition. The company focuses on the production of natto using proprietary strains of Bacillus subtilis var. natto, which are known for producing high levels of the fibrinolytic enzyme nattokinase and Vitamin K2. Kawaguchi Natto distinguishes itself by maintaining a vertically integrated production model, growing its own soybeans and rice straw to ensure the highest standards of quality and safety. Their product portfolio includes traditional straw-wrapped natto and dried natto products aimed at promoting cardiovascular and digestive health. As a key player in the functional food sector, the company bridges traditional Japanese dietary practices with modern health and wellness needs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kawaguchi Natto.